Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $4.09 Million - $4.4 Million
26,471 New
26,471 $4.38 Million
Q3 2021

Oct 29, 2021

SELL
$161.5 - $179.47 $4.85 Million - $5.38 Million
-30,000 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$153.07 - $170.48 $765,350 - $852,400
-5,000 Reduced 14.29%
30,000 $4.93 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $3.03 Million - $3.48 Million
-22,116 Reduced 38.72%
35,000 $5.51 Million
Q3 2020

Nov 09, 2020

BUY
$140.38 - $153.83 $3.77 Million - $4.13 Million
26,837 Added 88.63%
57,116 $8.5 Million
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $11.2 Million - $13.6 Million
-87,253 Reduced 74.24%
30,279 $4.26 Million
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $33,675 - $46,658
303 Added 0.26%
117,532 $15.4 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $14.9 Million - $17.2 Million
117,229 New
117,229 $17.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sector Gamma As Portfolio

Follow Sector Gamma As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.